Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)
|
April 28, 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
Donald R Nixon, Nicholas Flinn
Clinical Ophthalmology (Auckland, N.Z.)
|
November 19, 2021
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
Donald R Nixon, Nicholas Flinn, Claudia Enderlein
Molecules (Basel, Switzerland)
|
November 27, 2024
A Review of Sturge-Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways
Katharine Elizabeth Joslyn, Nicholas Flinn Truver, Anne Marie Comi
Immunology and Cell Biology
|
April 10, 2002
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology
Wendy A Hayman, Istvan Toth, Nicholas Flinn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Clinical Ophthalmology (Auckland, N.Z.)
|
April 28, 2021
Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor
Donald R Nixon, Nicholas Flinn
Clinical Ophthalmology (Auckland, N.Z.)
|
November 19, 2021
Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept
Donald R Nixon, Nicholas Flinn, Claudia Enderlein
Molecules (Basel, Switzerland)
|
November 27, 2024
A Review of Sturge-Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways
Katharine Elizabeth Joslyn, Nicholas Flinn Truver, Anne Marie Comi
Immunology and Cell Biology
|
April 10, 2002
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology
Wendy A Hayman, Istvan Toth, Nicholas Flinn, et al.
Page
of 1